eClinical Solutions Market Witness Growth Based On Increasing Number Of Clinical Research Activities Till 2022:Grand View Research,Inc.

Global e-clinical solution software market is expected to show significant growth over the forecast period as a consequence of rising number of clinical research activities. This rise in number of clinical research activities chipped in the need for sophisticated data management and standardization of data.

Additionally, it is mandatory for every organization to maintain error free documentation without manipulations as compliance to regulatory bodies. E-clinical software offers real time documentation hence give no scope for any further manipulations in data thereby, prompting the use of e-clinical software worldwide. Furthermore, these computer applications reduce data entry as well as data processing time substantially; this is an important factor boosting the growth of e-clinical solution software market.

Browse full research report on eClinical Solutions Market: http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

The market is divided on the basis of end-use, product and mode of delivery. The market based on end-use is divided into healthcare providers, pharmaceuticals and clinical research organizations. Pharmaceutical segment under end-use held lucrative share in 2014 as a result of immense investments made by pharmaceutical organizations in clinical research and development.

However, clinical research organization segment is expected to witness lucrative growth in coming seven years as a consequence of enduring trend of outsourcing, especially outsourcing clinical research operations which substantially saves time of companies and gives high compliance to the good clinical practices.

E-clinical solution software market on basis of product is divided into clinical data management system, clinical trial management system, trail supply management & safety solutions and randomization. Clinical data management systems had the largest share in 2014 as they have wide applications in pharmaceutical industry.

Market on the basis of mode of delivery is segmented into web based, cloud based and licensed enterprise. Web based software held the largest share in 2014 owing to their easy deliverability and upgradation. However, cloud based e-clinical solution software are expected to show significant growth in coming seven years due to benefits associated with them like remote access to data and safe & secure data management.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/healthcare-it

Global e-clinical solution software market is divided into North America, Europe, Asia Pacific, Latin America and MEA. North America held the largest market share in 2014 owing to developed infrastructure which provide high speed internet connection and highly configured computer systems. Additionally, multinational organizations in North America are mainly focused on new drug development hence, leading to high demand of these computer applications.

Asia Pacific is expected to witness significant growth over the forecast period as result of factors such as improvisation in healthcare policies with government initiatives and high demand of sophisticated technologies.

The key players contributing to e-clinical solution software market includes PAREXEL International, Medidata Solutions, BioClinica Inc., PHT Corporation, OmniComm Systems, DATATRAK International, Oracle Corporation and eResearch Technology. The strategies adopted by these market players include investment in developing regions such as Asia Pacific to meet the increasing demand and mergers & acquisitions to strengthen product portfolio to increase geographical reach.

Access press release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-e-clinical-solution-software-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
For more information: www.grandviewresearch.com


Comments

Post a Comment

Popular posts from this blog

Epigenetics Market to Observe Strong Development by 2022

The global  epigenetics market  is expected to reach USD 16.31 billion by 2022, according to a new report by Grand View Research, Inc. Growing worldwide prevalence of cancer and other diseases with epigenetic modification base is expected to drive market growth during the forecast period.  Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is expected to attract pharmaceutical companies to collaborate for the development of therapeutic drugs.  Presence of pipeline drugs and their expected commercialization is anticipated to boost penetration rates over the forecast period. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.  Technology advancements in the field of epigenetics especially pertaining to t
Read more

Increasing Incidences Of M&A Of CDMO/CRO With Big Pharma Companies To Drive Life Sciences BPO Market Growth Till 2024: Grand View Research, Inc.

Image
The  life sciences BPO market  is expected to reach USD 420 billion by 2024, according to a new report by Grand View Research, Inc. The lucrative growth is attributed to the growing demand for contract manufacturing of raw materials, Finished Dosage Forms (FDFs), medical devices, drug discovery services, regulatory services, pre-clinical and clinical trial services, and pharmacovigilance services.  The pharmaceutical and biotech industry invests heavily in the R&D sector to continuously introduce new molecules, devices, and treatments. The different stages of the drug development such as drug discovery, pre-clinical studies, and clinical trials require huge financial, technological, and human resources.  North America life sciences BPO market, by services, 2013 - 2024 (USD Billion) In order to cater to the growing needs of the industry, the outsourcing vendors are expanding their product and service offerings and they are targeting niche areas for long-term growth
Read more

U.S. Telehealth Market Is To Be $2.83 Billion By 2022: Grand View Research, Inc.

Image
U.S. telehealth market  is expected to reach USD 2.8 billion by 2022, according to a new report by Grand View Research Inc. Increasing access to basic healthcare is the major aim of telehealth along with improved healthcare quality and patient safety by early detection and diagnosis. According to a report published by the Agency for Health Care Research and Quality (AHRQ), implementation of telehealth solution improves quality of care delivery to patients.  The rising demand for self care and independent living along with the concept of home care is highly appealing to the population. The Rhode Island Partnership for Home Care reported that in 2014, over 20,000 citizens demanded for home care that led to approximately 1,000,000 visits by healthcare providers. Advantages that drive the higher adoption for home care include better psychological impact on patients, provision of friendly environment, care provision as per patient needs, and cost-effectiveness.  U.S. telehealth
Read more